ProShare Advisors’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32K | Sell |
11,070
-915
| -8% | -$2.64K | ﹤0.01% | 2036 |
|
|
2025
Q1 | $25.8K | Sell |
11,985
-2,885
| -19% | -$6.2K | ﹤0.01% | 2019 |
|
|
2024
Q4 | $57.5K | Buy |
+14,870
| New | +$57.5K | ﹤0.01% | 2161 |
|
|
2019
Q4 | – | Sell |
-843
| Closed | -$7K | – | 1795 |
|
|
2019
Q3 | $7K | Sell |
843
-334
| -28% | -$2.77K | ﹤0.01% | 1655 |
|
|
2019
Q2 | $17K | Sell |
1,177
-143
| -11% | -$2.07K | ﹤0.01% | 1613 |
|
|
2019
Q1 | $43K | Buy |
1,320
+11
| +0.8% | +$358 | ﹤0.01% | 1619 |
|
|
2018
Q4 | $78K | Buy |
+1,309
| New | +$78K | ﹤0.01% | 1500 |
|
|
2016
Q4 | – | Sell |
-1,624
| Closed | -$65K | – | 1747 |
|
|
2016
Q3 | $65K | Sell |
1,624
-301
| -16% | -$12K | ﹤0.01% | 1433 |
|
|
2016
Q2 | $138K | Buy |
1,925
+90
| +5% | +$6.45K | ﹤0.01% | 1488 |
|
|
2016
Q1 | $147K | Sell |
1,835
-190
| -9% | -$15.2K | ﹤0.01% | 1472 |
|
|
2015
Q4 | $153K | Buy |
2,025
+170
| +9% | +$12.8K | ﹤0.01% | 1596 |
|
|
2015
Q3 | $711K | Sell |
1,855
-109
| -6% | -$41.8K | 0.01% | 793 |
|
|
2015
Q2 | $816K | Buy |
1,964
+81
| +4% | +$33.7K | 0.01% | 863 |
|
|
2015
Q1 | $895K | Buy |
1,883
+507
| +37% | +$241K | 0.01% | 894 |
|
|
2014
Q4 | $509K | Buy |
+1,376
| New | +$509K | 0.01% | 1190 |
|